Introduction
============

Muscarinic acetylcholine receptors constitute a sub-family of G protein-coupled receptors (GPCRs) that act as metabotropic activators of the neurotransmitter acetylcholine (ACh). Five distinct subtypes have been identified (M1-M5), based on their G-protein coupling preferences ([@B97]). Downstream pathways activated include phospholipase C, inositol triphosphate (IP~3~), cyclic adenosine monophosphate (cAMP) and altered calcium homeostasis ([@B27]; [@B99]; [@B48]). In addition, these GPCRs modulate the cytoskeleton through trimeric G protein signaling ([@B41]). For example, α and βγ subunits of heterotrimeric G proteins modulate microtubule assembly ([@B71]; [@B77]). Activated Gα, acts as a GTPase activating protein (GAP) and increases microtubule disassembly by activating the intrinsic GTPase activity of tubulin ([@B69]).

The muscarinic acetylcholine type 1 receptor (M~1~R) is widely expressed in the central nervous system (CNS) ([@B51]; [@B98]; [@B40]) and peripheral nervous system (PNS) ([@B9]; [@B91]). Membranes isolated from hippocampus and cortex of M~1~R knockout (KO) mice showed a significant decrease in GTPγ-S loading to the Gα-q/11 G protein upon agonist stimulation ([@B28]). In cortical neuron cultures obtained from M~1~R KO mice, carbachol-stimulated phosphoinositide hydrolysis was reduced by 60% compared with wild type ([@B17]). In addition, phosphorylation of extracellular signal-regulated kinase (ERK) was eliminated in pyramidal neurons of hippocampal slices or cortical cultures derived from M~1~R KO mice ([@B8]; [@B36]).

In sympathetic neurons, ACh activation of M~1~R mobilizes internal Ca^2+^ stores leading to closure of M-type K^+^ channels (Kv7 subtypes) and enhancement of slow depolarization and discharge ([@B25]; [@B15]). In embryonic neurons, ACh modulates neurite outgrowth in a positive or negative manner based upon context ([@B90], [@B89]; [@B10]; [@B101]). Furthermore, both adult sensory dorsal root ganglia (DRG) neurons and epidermal keratinocytes synthesize and secrete ACh ([@B9]; [@B44]; [@B61]; [@B32]; [@B79]; [@B23]). Adult rat sensory neurons of the DRG express a peripheral form of ChAT (pChAT), exhibit ChAT activity, have low AChE activity and express multiple muscarinic receptors including M~1~R ([@B9]; [@B91]; [@B6]; [@B37]).

We have recently reported that selective or specific antagonists of M~1~R elevated neurite outgrowth and augmented mitochondrial function in adult sensory neurons ([@B18]). These drugs also afforded protection against several different forms of peripheral neuropathy. However, the mechanism of M~1~R antagonist-driven neurite outgrowth and neuroprotection has not been studied in detail. Mitochondrial oxidative phosphorylation is the main mechanism providing ATP to power neuronal activities such as production of presynaptic action potentials, neurotransmitter release, postsynaptic currents and postsynaptic action potentials ([@B35]). Mitochondria are known to concentrate in regions of active signaling and high metabolic demand ([@B20]; [@B59]; [@B95]). This substantial energy demand at the nerve ending or synapse implies that neurons must have a mechanism to maintain microtubules to augment mitochondrial trafficking upon demand ([@B83]; [@B81]).

In the present study we manipulated M~1~R expression/function in adult DRG sensory neurons and related cell lines and studied the cellular phenotypes and molecular consequences. Specifically, we tested the hypothesis that the M~1~R regulates the tubulin cytoskeleton, G-protein recruitment (Gα13 sub-type) and mitochondrial trafficking. We identified that excessive cholinergic signaling triggered tubulin destabilization through over-activation of Gα13 proteins. Further, we studied the ability of specific (muscarinic toxin 7: MT7) or selective (pirenzepine) M~1~R antagonists to ameliorate the endogenous and M~1~R overexpression-induced neuronal phenotypes that primarily result in a constraint on neurite outgrowth.

Materials and Methods {#s1}
=====================

All animal procedures followed guidelines of University of Manitoba Animal Care Committee using Canadian Council of Animal Care rules or of the Institutional Animal Care and Use Committee at UCSD.

Cell Culture
------------

Dorsal root ganglia from adult male Sprague-Dawley rats were dissected and dissociated using previously described methods ([@B2]; [@B67]; [@B74]). All animal protocols carefully followed the Canadian Committee on Animal Care (CCAC) guidelines. Neurons were cultured in defined Hams F12 media containing 10 mM [D]{.smallcaps}-Glucose (N4888, Sigma, St. Louis, MO, United States) supplemented with modified Bottenstein's N2 additives without insulin (0.1 mg/ml transferrin, 20 nM progesterone, 100 μM putrescine, 30 nM sodium selenite, 0.1 mg/ml BSA; all additives were from Sigma, St. Louis, MO, United States). In all experiments, the media was also supplemented with 0.146 g/L [L]{.smallcaps}-glutamine, a low dose or high dose cocktail of neurotrophic factors (Low dose = 0.1 ng/ml NGF, 1.0 ng/ml GDNF and 1 ng/ml NT-3, High dose = 1 ng/ml NGF, 10 ng/ml GDNF, 10 ng/ml NT3 -- all from Promega, Madison, WI, United States), 0.1 nM insulin and 1X antibiotic antimycotic solution (A5955, Sigma). Cultures were treated with 100 nM MT7 (M-200, Alomone Labs, Jerusalem, Israel) or 1 μM pirenzepine (P7412, Sigma).

HEK293 and HTLA cells were cultivated in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% heat inactivated FBS. The β-arrestin null (ARRB1 and ARRB2) and Gα12/13 (GNA12 and GNA13) null HEK293 cells were obtained from the laboratory of Dr. Asuka Inoue, Tohoku University, Japan. HTLA cells were provided by Prof Bryan Roth, University of North Carolina, United States.

Cloning, Transfection and siRNA Based Gene Silencing
----------------------------------------------------

Total mRNA was extracted from adult rat DRGs using Trizol reagent and used for amplifying the full length M~1~R cDNA using the following primer sets: F: 5′-ATGAACACCTCAGTGCCCCCTGC-3′ and R: 5′-TTAGCATTGGCGGGAGGGGGTG-3′. The cDNA was cloned in the pEGFP-C1 vector (Clontech, now Takara Bio United States, Inc., Mountain View, CA, United States) in the XhoI and SacII restriction sites. In addition, the cDNA was also cloned in the pHTN Halo-Tag CMV-neo Vector (Promega, Madison, WI, United States) at the SacII and Not1 restriction sites. The plasmids were transiently transfected in freshly dissociated sensory neurons using the rat neuron nucleofection kit (VPG-1003, Amaxa, Lonza Inc., Allendale, NJ, United States) and Amaxa nucleofector-II apparatus (program 0-003) and cultured in poly [L]{.smallcaps}-Ornithine (P8638, Sigma) and laminin coated μ-Plate-24 well (Ibidi United States, Inc., Madison, WI, United States). The human M1-DREADD construct was obtained from Dr. Arthur Christopoulos, Monash University, Australia and sub-cloned in pEGFP-C1 vector ([@B1]). The rat Gα13(GNA13) was knocked down using a cocktail of three siRNAs targeted to exon 2 (AGTATCTTCCTGCTATAAGAGCC) and exon 4 (CTACATTCCGTCACAGCAAGATA and CATCAAAGACTATTTCCTAGAAT), respectively. The siRNAs were transfected in to primary sensory neurons using Amaxa transfection reagent.

Quantification of Neurite Outgrowth
-----------------------------------

The transgene transfected neurons were cultured for 48 h and then cells were fixed in 4% paraformaldehyde for 10 min and immunostained using monoclonal anti-β-tubulin III antibody. The neurons were also stained with Hoechst for nuclear staining. The neurons were imaged in an unbiased manner using a Cellomics Arrayscan-VTI high content screening (HCS) Reader (Thermo Fisher Scientific, Waltham, MA United States) and total neurite outgrowth per neuron was measured by Neuronal Profiling V4.1 software. The automated HCS reader provided a bias-free objective analysis of neurite outgrowth.

Confocal Microscopic Image Acquisition and Analysis to Determine Mitochondrial Volume and Trafficking
-----------------------------------------------------------------------------------------------------

Mitochondrial trafficking in GFP or GFP-M~1~R overexpressing neurons was monitored using LSM510 confocal live cell imaging and involved co-transfection of sensory neurons with GFP/GFP-M~1~R and DsRed2Mito7 plasmids (Addgene plasmid \#55838, a gift from Dr. Michael W. Davidson, Florida State University), respectively. The DsRed2Mito7 consists of a mitochondrial targeting sequence from subunit VIII of human cytochrome C oxidase which is placed before the Red fluorescence protein and the resultant fusion protein selectively accumulates inside the mitochondria ([@B94]). The transfected cells were live imaged at 10 s interval for 80 time frames (∼13 min). The time lapse images were used to generate kymographs using the ImageJ make kymograph plugin ([@B80]). In each kymograph, the *x*-axis represents the position along the length of the axon and the *y*-axis represents time. Vertical lines indicate stationary mitochondria with no displacement during the time elapsed and diagonal lines represent moving mitochondria and their direction. Their velocity is reflected in the slope of the line. In addition we used Fiji ([@B78]) based MTrackJ to determine mitochondrial velocity (μm/sec) in the neurites ([@B58]). The volume of mitochondria in the neurites was calculated by using Image J analyze particles plugin and expressed in μm per neurite length ([@B78]).

Western Blotting and Immune-Detection
-------------------------------------

Relative quantification of proteins was done by SDS-PAGE separation of total proteins followed by transfer to nitrocellulose membrane and immunoblotting based detection using HRP-conjugated secondary antibodies. The immunoblots were imaged in Bio-Rad Chemidoc system (Bio-Rad Laboratories Ltd., Mississauga, ON, Canada). **Table [1](#T1){ref-type="table"}** summarizes all the primary antibodies used in this study. The cell lysates were prepared in 1X RIPA lysis and extraction buffer (Cat No: 89900, Thermo Fisher Scientific) supplemented with 1X Halt protease and phosphatase inhibitor cocktail (Cat No: 78441, Thermo Fisher Scientific).

###### 

List of antibodies.

  Name of the antibody; clone number   Catalog number    Host species and type   Vendor
  ------------------------------------ ----------------- ----------------------- --------
  Anti-porin (B-6)                     Sc-390996         Mouse monoclonal        SCBT
  Anti-β-actin (C-4)                   Sc-47728          Mouse monoclonal        SCBT
  Anti GAPDH (0411)                    Sc-25778          Mouse monoclonal        SCBT
  Anti-α-tubulin (TU-02)               Sc-8035 (TU-02)   Mouse monoclonal        SCBT
  Anti-GFP                             Sc-9996           Mouse monoclonal        SCBT
  Anti-M~1~R                           Sc-365966         Mouse monoclonal        SCBT
  Anti-Gγ2/3/4/7                       Sc-166419         Mouse monoclonal        SCBT
  Anti-Gα12/13                         Sc-28588          Mouse monoclonal        SCBT
  Anti-β-tubulin III                   T8578             Mouse monoclonal        Sigma

SCBT, Santa Cruz Biotechnology.

Polymerized Tubulin Quantification
----------------------------------

The polymerized tubulin in M~1~R overexpressed cells (40--50% transfection efficiency) was quantified by methods described previously ([@B16]). Briefly, the soluble fraction of tubulin was first removed by lysing the cells in a microtubule stabilizing buffer (MSB) containing 50% glycerol, 5 mM MgCl~2~, 0.1 mM EGTA, 0.3 mM guanosine triphosphate (grade II-S, Sigma Chemical Co.), and 10 mM sodium phosphate, pH 6.8 ([@B5]). Cells were harvested with a rubber scraper in MSB, homogenized, and centrifuged at 26,000 × *g* in a Sorvall RC2-B centrifuge (17,000 rpm in rotor SS-34 in 1.0 ml tubes; Dupont Instruments-Sorvall Biomedical Div., Dupont Co., Newtown, CT, United States) at 20°C for 30 min. Supernatants containing the soluble tubulin fraction were removed and the pellet containing polymerized tubulin and other cytoskeletal protein was assessed by immunoblotting using anti-actin and anti-β tubulin III antibodies.

Halo-M~1~R Pull Down and Blue-Native Polyacrylamide Gel Electrophoresis (BN-PAGE)
---------------------------------------------------------------------------------

SH-SY5Y human neuroblastoma cells (provided by Dr. Jun-Feng Wang, University of Manitoba) were grown in dulbecco's modified eagle medium: nutrient mixture F-12 (DMEM/F12, Thermo Fisher) supplemented with 10% fetal bovine serum (FBS, Thermo Fisher). Halo-M~1~R plasmid was transiently expressed in SH-SY5Y cells that were treated with 100 nM MT7 or 1 μM pirenzepine for 1 h. Halo-M~1~R was then pulled down using Halo-link resin by overnight incubation at 4°C (Promega Corporation, Madison, WI, United States) as per manufacturer's instruction and the pull-down product was cleaved using TEV-protease (Promega) overnight on a constant rotating shaking platform. The cleaved fraction was resolved in SDS-PAGE and immunoblotted using anti-M~1~R, anti Gγ2/3/4/7 and anti-Gα12/13 antibodies. The BN-PAGE was performed as described previously ([@B72]). Polymeric tubulins in Gα12/13 null and native HEK293 cells were separated by BN-PAGE using microtubule stabilizing native cell lysis buffer containing 20 mM Bis-tris (pH7.0), 500 mM ε-aminocaproic acid, 20 mM NaCl, 10% Glycerol, 5 mM MgCl~2~, and 0.3 mM GTP ([@B5]).

Isoelectric Focusing
--------------------

Fifty microgram of total cellular protein was precipitated by acetone and dissolved in rehydration buffer containing 8 M Urea, 2% CHAPS, 50 mM dithiothreitol (DTT) and 0.2% Bio-Lyte ampholytes pH3-10. The dissolved proteins were incubated in Zoom IPG-strip 3-10 non-linear (NL) (Thermo Fisher) for 1 h and then focused at 175 volt (V) for 15 min, 175--2000 V ramp for 45 min and 2000 V for 30 min. After the run, the strips were alkylated and resolved on 2D SDS-PAGE and immunoblotted using antibodies previously described.

Statistical Analysis
--------------------

Statistical analysis was performed using Prism version 7.00 (GraphPad Software). The mean of two or more groups were compared using one-way ANOVA followed by multiple comparison tests ([@B85]; [@B26]). The mean of multiple experimental groups were compared with the control group by Dunnett's *post hoc* multiple comparison test, whereas, the mean difference between two experimental groups were compared by Sidak's *post hoc* multiple comparison test ([@B26]). Comparisons between two groups were performed using Student's *t*-test (unpaired). Differences were considered significant at *P* \< 0.05. Neurite outgrowth, neurite width and mitochondrial quantification data were plotted as box and whisker plot where the end of the box represents the upper and lower quartiles and the median is marked by a horizontal line inside the box. The whiskers represent the highest and lowest values excluding the outliers. In some figures the individual data points of outliers are also indicated.

Results
=======

MT7 and Pirenzepine Significantly Augmented Neurite Outgrowth in Cultured Primary Sensory Neurons
-------------------------------------------------------------------------------------------------

Pirenzepine is a selective M~1~R antagonist whereas MT7 is the only specific antagonist of this receptor ([@B13]; [@B55]). Our previous study demonstrated that both antagonists enhanced neurite outgrowth from adult sensory neurons ([@B18]). In order to confirm that MT7 and pirenzepine had growth promoting effects under the current conditions, we measured total neurite outgrowth from primary sensory neurons derived from adult rats and cultured in defined media containing a cocktail comprising of low or high concentrations of GDNF, NGF, and NT3 growth factors (LGF and HGF, respectively) and either 100 nM MT7 or 1 μM pirenzepine (**Figures [1A](#F1){ref-type="fig"}--[D](#F1){ref-type="fig"}**). The growth factor concentrations in the LGF cocktail reflects concentrations of growth factors that are sub-saturating and induce small but significant increases in neurite outgrowth ([@B18]). The HGF cocktail contained 10-fold higher concentrations to allow us to determine whether the neuritogenic effects of MT7 and pirenzepine were also effective when growth factors were present in excess and, also to see if increased tyrosine kinase signaling masked the effect of antagonist-M~1~R signaling mediated growth. In the absence of muscarinic antagonists, the HGF promoted significantly (*p* \< 0.0001) more neurite outgrowth than LGF, as assessed using unbiased automated high content imaging combined with data analysis (**Figures [1A,B](#F1){ref-type="fig"}**). Both MT7 and pirenzepine significantly increased neurite outgrowth in LGF and HGF conditions within 48 h of treatment (**Figures [1A,B](#F1){ref-type="fig"}**). In addition, binning of the entire data set of 1249 (LGF) and 1517 (HGF) neurons for their total neurite length revealed that the neuritogenic effect of pirenzepine and MT7 evenly affected neurite outgrowth of the majority of the population of neurons (**Figures [1C,D](#F1){ref-type="fig"}**). Further, pirenzepine treatment elicited significantly higher neurite outgrowth under the LGF conditions when compared to MT7, whereas under the HGF condition, the primacy was reversed (**Figures [1A,B](#F1){ref-type="fig"}**). The exact reason for the difference between the drugs in terms of synergistic effect on growth at HGF condition is not known. The difference in the chemical nature of these drugs may be responsible. MT7 is a cell impermeable 7.4 kDa protein ([@B46]) which binds allosterically to M~1~R ([@B56]; [@B42]) whereas pirenzepine is a cell-permeable orthosteric antagonist molecule ([@B19]). We used LGF conditions in subsequent experiments.

![M~1~R antagonists, MT7 and pirenzepine, augment neurite outgrowth in primary sensory neurons and M~1~R overexpression inhibits neurite outgrowth. **(A,B)** Whiskers box (Tukey) showing total neurite outgrowth per neuron. Neurons were grown for 48 h in defined media containing LGF **(A)** or HGF **(B)** condition and treated with 100 nM MT7 or 1 μM pirenzepine (PZ), respectively. *N* = 1249 (LGF) and 1517 (HGF), respectively. *P*-values were calculated by one-way ANOVA followed by *post hoc* multiple comparison tests. Dunnett's multiple comparisons test was used to compare the MT7 and PZ treatment groups with the control group and Sidak's multiple comparisons test was used to compare between the MT7 and PZ treatment groups; ^∗^ indicates the *p*-value obtained by Sidak's multiple comparisons test. **(C,D)** Binning of the entire data set presented in **(A,B)**. **(E)** Immunoblot showing GFP-tagged muscarinic receptors (M~1~R to M~5~R) and GFP expression in transfected adult rat DRG neurons. pEGFP-C1-(M~1~R-M~5~R) plasmids were transfected in to DRG neurons and the lysate was resolved in SDS page and subsequently immunoblotted with anti-M~1~R (bottom panel) and anti-GFP (top panel) antibodies. **(F)** Time lapse confocal images showing increasing internalization (white arrows) of the GFP-M~1~R following treatment with carbachol (10 μM). Scale bar: 10 μm. **(G)** Immunofluorescence images showing colocalization of 24h CCh treated GFP-M1R with endosomal marker Rab5. Scale bar: 10 μm. **(H)** Whiskers box (Tukey) showing total neurite outgrowth per neuron, *N* = 634 (GFP), and *N* = 553 (GFP-M~1~R), neurons, respectively. *P*-value was calculated by *t*-test (unpaired). **(I)** Immunofluorescence images showing β-tubulin III staining and corresponding neurite trace (red lines) images in GFP and GFP-M~1~R overexpressed neurons. The total neurite outgrowth measurement was performed in Cellomics ArrayScan HCS Reader using neuronal profiling software. Scale bar: 10 μm.](fnins-12-00402-g001){#F1}

M~1~R Overexpression Induced Significant Reduction in Neurite Outgrowth
-----------------------------------------------------------------------

The muscarinic receptor subtypes (M1--M5) show considerable heterogeneity of expression in sensory neurons([@B9]; [@B21]). In order to understand the biological function of M~1~R in sensory neurons, we overexpressed GFP-tagged M~1~R in sensory neurons and measured the impact on neurite outgrowth. M~1~R overexpression significantly reduced neurite outgrowth when compared to GFP-expressing neurons (**Figures [1H,I](#F1){ref-type="fig"}**). The GFP-M~1~R transgene-induced protein production was verified in the transfected DRG neurons by immunoblotting of the expressed recombinant proteins (GFP-M1-5R) using both anti-M~1~R and anti-GFP antibodies (**Figure [1E](#F1){ref-type="fig"}**). The biological functionality of the GFP-M~1~R recombinant protein was verified by treating GFP-M~1~R overexpressing DRG neurons with the broad spectrum muscarinic agonist carbachol (10 μM) followed by live confocal imaging to monitor internalization of recombinant protein. Treatment with carbachol increased presence of the recombinant protein as internalized spots that were positive for the early endosomal marker Rab5 ([@B102]) (**Figures [1F,G](#F1){ref-type="fig"}**). This indicates that GFP-tagged recombinant M~1~R elicited agonist induced internalization response similar to that of naïve proteins. In addition, to assess functionality of the recombinant M~1~R in overexpressed cells, we performed a β-arrestin recruitment assay \[TANGO assay: ([@B47]), **Figure [2](#F2){ref-type="fig"}**\]. In the TANGO assay, upon activation, β-arrestin is recruited to the C-terminus of the M~1~R-TEV-tTA fusion protein at the TEV protease site and cleaves to release the tTA transcription factor, which after transport to the nucleus activates transcription of luciferase reporter gene ([@B47]) (**Figure [2A](#F2){ref-type="fig"}**). We verified expression of the M~1~R-TEV-tTA and β-arrestin transgenes by immunoblotting (**Figure [2B](#F2){ref-type="fig"}**). We found significant recruitment of β-arrestin due to basal M~1~R activation in presence of serum in the culture media in the HTLA cells (**Figure [2C](#F2){ref-type="fig"}**). This basal activation of M~1~R occurred in the absence of exogenously supplied agonist. However, fetal bovine serum (FBS) used in the culture media is reported to contain acetylcholine (ACh) ([@B50]) and this may have constitutively acted upon the M~1~R. Treatment with the muscarinic agonist, carbachol, significantly increased activation of the M~1~R by up to ∼7.4-fold (**Figure [2C](#F2){ref-type="fig"}**).

![Constitutive basal activity of M~1~R and the effect of DREADD mutant on neurite outgrowth. **(A)** Graphical representation of the arrestin recruitment assay (TANGO) strategy, TRE-Tet response element. HA-cleavable signal sequence to promote membrane localization, FLAG-epitope tag, TEV- Tobacco Etch Virus cleavage site, V~2~ tail: C-terminus of the V~2~ vasopressin receptor (V~2~ tail) to promote arrestin recruitment and tTA- tetracyclin transactivator. **(B)** Immunoblot showing expression of M~1~R-TEV-tTA and β-arrestin-TEV protease transgene. **(C)** Scatter plot showing the RLU (Relative Luminescence Units) for the drug treated HTLA cells. *N* = 5 independent experiments. **(D)** Co-expression of GFP/GFP-M~1~R/GFP-M~1~R(DREADD) with mito7-RFP in DRG neurons following 48 h of growth. Neurite outgrowth suppression was comparatively less in M~1~R-DREADD mutant over-expressing neurons. The white and blue arrows indicate that localization of GFP-M~1~R was mainly restricted in the perikaryon where as GFP was localized both in perikaryon and neurites. LSM510 confocal images acquisition parameters were same for all images. Scale bar: 100 μm. **(E)** Whiskers box (Tukey) showing total neurite outgrowth per neuron. *N* = 250. *p*-value by one-way ANOVA followed by Dunnett's multiple comparisons test. **(F)** Binning of the entire data set presented in **(E)**.](fnins-12-00402-g002){#F2}

Endogenous ACh Binds M~1~R to Constrain Neurite Outgrowth
---------------------------------------------------------

Adult sensory neurons secrete ACh into the extracellular media when grown in culture ([@B18]). The Tango Assay revealed that ACh present in the serum supplied to the culture media may also act upon M~1~R and constitutively activate the receptor. We therefore hypothesized that overexpression of M~1~R in sensory neurons may lead to increased constitutive activation of the receptor by recruitment of trimeric G-proteins, including the Gα12/13 subtype that promotes tubulin destabilization ([@B69]). In order to test this hypothesis we transfected DRG neurons with an M~1~R-DREADD ([d]{.ul}esigner [r]{.ul}eceptors [e]{.ul}xclusively [a]{.ul}ctivated by [d]{.ul}esigner [d]{.ul}rugs) mutant to eliminate the putative basal activity in M~1~R-DREADD overexpressing neurons (**Figures [2D,E](#F2){ref-type="fig"}**). The M~1~R-DREADD mutant contained two mutations in the conserved orthosteric site residues (Y106C and A196G in the M~1~R) that minimize responsiveness to ACh ([@B1]). Overexpression of GFP-M~1~R and M~1~R-DREADD caused low levels of neurite outgrowth (**Figures [2D](#F2){ref-type="fig"}--[F](#F2){ref-type="fig"}**). However, neurite outgrowth in M~1~R-DREADD neurons was significantly higher than GFP-M~1~R alone over 72 h of culture (**Figures [2D](#F2){ref-type="fig"}--[F](#F2){ref-type="fig"}**). This indicates that endogenous ACh may interact with M~1~R to limit neurite outgrowth.

Impact of M~1~R Overexpression on Mitochondrial Abundance
---------------------------------------------------------

In an attempt to understand the mechanism of the growth inhibitory effect of M~1~R overexpression, we examined the abundance of mitochondria in the neurites by co-expressing DsRed2Mito7 plasmid (**Figure [3A](#F3){ref-type="fig"}**). The DsRed2Mito7 plasmid expresses DsRed protein tagged with mitochondrial targeting sequence from subunit VIII of human cytochrome C oxidase and therefore localizes specifically to mitochondria. We measured the volume of mitochondria present per unit length (μm) of neurites in the M~1~R and GFP overexpressing DRG neurons (**Figure [3B](#F3){ref-type="fig"}**). M~1~R overexpression significantly reduced the abundance of mitochondria in the neurites after 48 h of culture (**Figures [3C,D](#F3){ref-type="fig"}**). The mitochondria in both M~1~R and GFP over-expressing neurons accumulated mitotracker CMXRos dye, indicating that functionality of the mitochondria was not impaired in M~1~R overexpressed neurons despite reduced abundance (data not shown).

![GFP-M~1~R over-expression in sensory neurons caused reduced mitochondrial abundance. **(A)** Representative images showing the signal of co-expression of GFP/GFP-M~1~R and mito7-RFP in DRG neurons. BF, bright field. **(B)** Immunofluorescence images showing mito7-RFP and β-tubulin III stained neurites. The 4th panel image showing tracing of the mitochondrial volume used for determining the amount of mitochondria per unit length of the neurites in GFP/GFP-M~1~R overexpressed DRG neurons. The tracing image was created using ImageJ particle counter plugin. Scale bar: 5 μm. **(C)** Whiskers box (min--max) showing amount of mitochondria in GFP/GFP-M~1~R transfected neurons. *N* = 101 from three independent experiments, *p*-value by *t*-test (unpaired). **(D)** Binning of the entire data set presented in **(C)**.](fnins-12-00402-g003){#F3}

Reduced Mitochondrial Abundance Was Associated With Impaired Cytoskeletal Structure
-----------------------------------------------------------------------------------

To determine whether reduced mitochondrial abundance was related to a defect in the actin or tubulin cytoskeletons, we immunostained DRG neurons that overexpressed GFP/GFP-M~1~R with phalloidin and anti-β-tubulin III antibodies. In the presence of M~1~R over-expression, immunofluorescent imaging of phalloidin revealed the presence of abundant and continuous actin filaments in the neurites, although the neurite tips were notably thinner compared to those of GFP expressing neurites (**Figure [4A](#F4){ref-type="fig"}**). In contrast, the β-tubulin III associated cytoskeleton appeared less abundant and discontinuous (**Figure [4B](#F4){ref-type="fig"}**). Fragmentation of the tubulin cytoskeleton was confirmed using a polymerized tubulin quantification assay in which there was significantly less polymerized tubulin in the DRG neurons overexpressing M~1~R compared to those that overexpressed only GFP (**Figures [4C,D](#F4){ref-type="fig"}**).

![Dorsal root ganglia (DRG) neurons over-expressing M~1~R exhibited cytoskeletal defects. **(A)** Actin cytoskeleton in GFP-M~1~R and GFP over-expressing DRG neurons. White arrow indicates narrower neurites in GFP-M~1~R expressing neurons. **(B)** β-tubulin III associated cytoskeleton in GFP-M~1~R and GFP over-expressing neurons. Black rectangular area is shown in a magnified view in the right panel; white arrow indicates discontinuous/continuous tubulin cytoskeleton. BF, bright field. Scale bar: 20 μm. **(C)** Immunoblot and **(D)** bar graph showing relative amount of polymerized tubulin in the M~1~R-GFP and GFP over-expressed neurons. The data represent the mean ± SEM of three independent experiments. *P* = 0.0011 calculated by unpaired *t*-test.](fnins-12-00402-g004){#F4}

Discontinuous Tubulin Cytoskeleton Was Associated With Reduced Mitochondrial Trafficking in Sensory Neurons Overexpressing M~1~R
--------------------------------------------------------------------------------------------------------------------------------

In order to determine whether the discontinuous β-tubulin cytoskeleton was associated with altered mitochondrial trafficking in growing neurites, we measured velocity of mitochondrial movement in the neurites of DRG neurons that co-expressed GFP/GFP-M~1~R and DsRed2Mito7. Time-lapse images of the neurites at 10 s intervals were used to generate kymographs of mitochondrial trafficking (**Figure [5A](#F5){ref-type="fig"}**). The mean velocity of mitochondria was calculated as 1.9 μm/sec in GFP expressing neurons whereas in GFP-M~1~R expressing neurons it was significantly lower at 0.62 μm/sec (**Figures [5B,C](#F5){ref-type="fig"}**). In addition, immunostaining of neurites with a similar appearance to those used in the mitochondrial velocity measurement revealed a continuous β-tubulin-III cytoskeleton in GFP over-expressed neurons and a discontinuous β-tubulin-III cytoskeleton in M~1~R over-expressed neurons (**Figures [5D,E](#F5){ref-type="fig"}**).

![Altered mitochondrial trafficking in M~1~R overexpressing neurons was rescued by antagonist treatment. **(A)** Representative images (top panels) of the first frame of a series of live cell time-lapse images showing the expression of DsRed2Mito7 in the mitochondria of GFP/M~1~R--GFP expressing neurons. The circles represent mitochondria identified by MTrackJ plugin, which then tracked migration through time in a series of time lapse images and calculated velocity of specific mitochondria. White/blue line represents neurite trace. The bottom panel represents Kymographs generated from live cell time-lapse images. The Kymograph was generated using ImageJ Kymograph plugin. The *X*-axis represents the physical location of mitochondria on the neurite, and the *Y*-axis represents the location of mitochondria in time. Streak of particles traversing the kymograph from left to right in angular lines indicates retrograde/anterograde mitochondrial motion. **(B)** Whisker plot showing mitochondrial velocity. DRG neurons were cultured in LGF media supplemented with 100 nM MT7 or 1 μM pirenzepine for 48 h following transfection. *N* = 40 from three independent experiments, *p*-value by one-way ANOVA followed by Dunnett's multiple comparisons test. **(C)** Binning of the entire data set presented in **(B)**. **(D,E)** Immunofluorescence images showing mito7-RFP and β-tubulin-III staining in the GFP/GFP-M~1~R expressing neurites. White arrows indicate continuous/discontinuous tubulin cytoskeleton in GFP/GFP-M~1~R expressing neurites, respectively. Scale bar: 5 μm.](fnins-12-00402-g005){#F5}

Muscarinic Antagonists MT7 and Pirenzepine Rescued the Cytoskeletal Defect, Aberrant Mitochondrial Distribution and Trafficking in Neurites
-------------------------------------------------------------------------------------------------------------------------------------------

We investigated whether pirenzepine or MT7 could overcome M~1~R overexpression-induced cytoskeletal defects. M~1~R over-expressing neurons were maintained for 48 h and then treated for 24 h with 100 nM MT7 or 1 μM pirenzepine and total neurite outgrowth and mitochondrial velocity (**Figure [5](#F5){ref-type="fig"}**) and abundance (**Figure [6](#F6){ref-type="fig"}**) quantified. MT7 and pirenzepine treatment significantly rescued the deficits in the mitochondrial velocity in M~1~R overexpressed neurons, with mean mitochondrial velocities of 0.78/1.2 μm/s in MT7/pirenzepine treated neurons being significantly higher than untreated neurons (**Figures [5B,C](#F5){ref-type="fig"}**). Both MT7 and pirenzepine also caused considerable re-localization of M~1~R from the perikarya to the neurites, as revealed by time lapse confocal live cell images over a period of 72 h. This may indicate increased vesicular transport of internalized M~1~R (**Figure [6A](#F6){ref-type="fig"}**). Within the same neuron (shown in **Figure [6A](#F6){ref-type="fig"}**), following 24 h of drug treatment and upon fixation and immunostaining for β-tubulin III, there was continuity in the β-tubulin III associated cytoskeleton (right panel). MT7 or pirenzepine significantly increased total neurite outgrowth, reversed the reduced neurite caliber and increased mitochondrial abundance in DRG neurons that overexpressed GFP-M~1~R (**Figures [6B](#F6){ref-type="fig"}--[E](#F6){ref-type="fig"}**).

![Restoration of cytoskeleton, mitochondrial abundance and neurite outgrowth by M~1~R antagonists MT7 and pirenzepine treatment. **(A)** Time-lapse live confocal images of GFP-M~1~R over-expression in sensory neurons showing MT7 induced re-localization of M~1~R from perikaryon to neurites. The overexpressed neurons were grown in defined media for 48 h and imaged (left panel). Neurons were then treated with 100 nM MT7 for 24 h and imaged (middle panel). Right panel: The same neuron depicted left was fixed and stained for β-tubulin III to show continuity of cytoskeleton. Scale bars: 50 μm. **(B,C)** Whiskers box (Tukey) showing total neurite outgrowth per neuron **(B)** and average neurite width per neuron **(C)**. *p*-value calculated by one-way ANOVA, *N* = 224, 230 and 198 cells, respectively, for **(A)** and *N* = 1250, 1268, 1280, and 1306 cells, respectively, for **(B)**. Asterisks indicate *p*-value calculated by unpaired *t*-test. **(D)** Whisker box plot showing amount of mitochondria in the M~1~R expressing neurons treated with 100 nM MT7 or 1 μM pirenzepine. *N* = 101, *p*-values were calculated by one-way ANOVA followed by Dunnett's multiple comparisons tests. **(E)** Binning of the entire data set presented in **(D)**.](fnins-12-00402-g006){#F6}

Knockdown of Gα13 in Sensory Neurons Reversed the M~1~R Overexpression-Induced Tubulin Cytoskeleton Defect
----------------------------------------------------------------------------------------------------------

The M~1~R-DREADD mutant study raised the possibility that, in normal DRG neurons, basal M~1~R activity resulting from binding of endogenous ACh release may destabilize the tubulin cytoskeleton through increased active G proteins. Gα12/13 proteins are known for their effect on cytoskeleton remodeling and the M~1~R receptor activates Gα12/13 type G proteins leading to mobilization of the small GTP-binding protein Rho through activation of Rho-GEF (RhoGTPase nucleotide exchange factor) ([@B33]). We, therefore, measured the relative expression of Gα12 and Gα13 proteins in sensory neurons (**Figure [7A](#F7){ref-type="fig"}**). Immunoblots revealed that DRG neurons express significantly more Gα13 compared to Gα12 (**Figures [7A,B](#F7){ref-type="fig"}**). The relative levels of Gα12 and Gα13 expression were comparable to those of the human carcinoma cell line HEK293 (**Supplementary Figure [S1A](#SM1){ref-type="supplementary-material"}**). We used siRNA to knockdown Gα13 in DRG neurons and used a CRISPR/Cas9 based Gα12/13 null HEK293 cell line to study the effect of cholinergic signaling through Gα13 on the tubulin cytoskeleton (**Figure [7C](#F7){ref-type="fig"}** and **Supplementary Figure [S1A](#SM1){ref-type="supplementary-material"}**). The HEK293 cell line has been reported to exhibit a neuronal lineage phenotype and express neuronal proteins ([@B87]). Therefore, we considered it suitable for this study. The siRNA based knockdown of Gα13 in DRG neurons had no significant effect on neurite outgrowth (**Figures [7D,E](#F7){ref-type="fig"}**). Interestingly, knockdown of Gα13 in M~1~R overexpressed sensory neurons significantly reversed the suppressed neurite outgrowth (**Figures [7F,G](#F7){ref-type="fig"}**). In addition, treatment of the M~1~R overexpressed and Gα13 knockdown neurons with 100 nM MT7 or 1 μM pirenzepine exhibited significantly increased neurite outgrowth (**Figures [7F,G](#F7){ref-type="fig"}**).

![Knockdown of Gα13 reversed M~1~R overexpression-induced inhibition of neurite outgrowth. **(A)** Immunoblots showing relative expression of Gα12 and Gα13 proteins in cultured DRG neurons. **(B)** Scatter plot showing relative amount of Gα12 and Gα13 proteins in cultured sensory neurons. *N* = 5 independent experiments. *p*-value was calculated by unpaired *t*-test. **(C)** Immunoblots showing siRNA (cocktail of 3 siRNAs targeted to rat Gα) based knockdown of Gα13 protein in cultured adult rat DRG neurons. **(D,F)** Whisker box (Tukey) showing total neurite outgrowth per neuron. DRG neurons were transfected with a pEFGP-C1-M~1~R plasmid and siRNA using Amaxa nucleofection reagent and allowed to grow for 48 h. Scrambled siRNAs were used for control. In drug treatment groups, neurons were cultured in media supplemented with 100 nM MT7 or 1 μM pirenzepine following transfection. The neurons were fixed after 48 h of culture, stained with β-tubulin III and imaged using Cellomics ArrayScan HCS Reader. *p*-value by unpaired *t*-test or one-way ANOVA test followed by Dunnett's multiple comparisons tests. *N* = 432/452 (in **D**) and 406/694 (in **F**). **(E,G)** Binning of the entire data set presented in **(D,F)**.](fnins-12-00402-g007){#F7}

CRISPR/Cas9 Based Gα12/13 Null HEK293 Cells Showed Abundant Tubulin Cytoskeleton but Diminished Actin Stress Fibers
-------------------------------------------------------------------------------------------------------------------

RNA sequencing data in the human protein atlas (HPA) indicates that HEK293 cells express very high levels of α-tubulin compared to β-tubulin III ([@B93]). The transcripts per million bases (TPM) value for α-tubulin (TUBA1B isoform) and β-tubulin III has been recorded as 1923.6 and 13.7, respectively^[1](#fn01){ref-type="fn"}^. β-tubulin III was undetectable by immunoblotting in HEK293 cells (data not shown). We, therefore, studied α-tubulin dynamics in CRSIPR/Cas9 based Gα12/13 knockout HEK293 cells. We performed immunofluorescent labeling using phalloidin and anti-α-tubulin specific antibodies to visualize the actin and tubulin based cytoskeletal structures in Gα12/13 knockout HEK293 cells (**Supplementary Figure [S1E](#SM1){ref-type="supplementary-material"}**). Phalloidin staining revealed that actin stress fibers were diminished in Gα12/13 null cells, with appearance of abundant distinct punctate actin rich focal adhesion points (**Supplementary Figure [S1E](#SM1){ref-type="supplementary-material"}**). Further, the tubulin cytoskeleton appeared more robust and organized in Gα12/13 null cells (**Supplementary Figures [S1E](#SM1){ref-type="supplementary-material"}**, **[S2](#SM2){ref-type="supplementary-material"}**). The BN-PAGE based microtubule fractionation assay and polymerized microtubule quantitative assay showed Gα12/13 null cells exhibited significantly more polymerized tubulin than wild type HEK293 cells (**Supplementary Figures [S1B--D](#SM1){ref-type="supplementary-material"}**). Overexpression of M~1~R in Gα12/13 null cells and treatment with muscarinic agonist carbachol did not alter the tubulin networks as compared to wild type cells (**Supplementary Figures [S2](#SM2){ref-type="supplementary-material"}**, **[S3](#SM3){ref-type="supplementary-material"}**).

MT7 and Pirenzepine Modulate G Protein Interaction With the M~1~R
-----------------------------------------------------------------

Adult DRG cultures have very low cell yields, in the range of 250,000 per culture. To enable feasible pull down of protein complexes we used human neuroblastoma SH-SY5Y cultures that allow use of millions of cells. This cell line also exhibits a cholinergic phenotype with ACh secretion, expression of muscarinic receptors and AChE shedding ([@B100]). We examined the recruitment of trimeric G proteins to M~1~R by Halo-pull down assay and BN-PAGE analysis (**Figures [8](#F8){ref-type="fig"}**, **[9](#F9){ref-type="fig"}**). The Halo-pull down assay permitted a focus on the over-expressed M~1~R with no contamination from endogenous muscarinic receptors of mixed sub-type. The SH-SY5Y cells that overexpressed Halo-M~1~R were treated with drugs and Halo-tagged M~1~R was pulled down using Halo-linked resin. Subsequently, the pull down product was resolved in SDS-PAGE and immunoblotted with anti-M~1~R, anti-Gα12/13 and anti-Gγ/2/3/4/7 antibodies (**Figures [8B](#F8){ref-type="fig"}--[D](#F8){ref-type="fig"}**). The Halo-M~1~R pull down fraction from the drug treated cells showed significantly elevated levels of Gγ/2/3/4/7 and Gα12/13 proteins when compared with untreated cells (**Figures [8E,F](#F8){ref-type="fig"}**).

![MT7 and pirenzepine elevated sequestration of trimeric G proteins associated with M~1~R in SH-SY5Y cells. **(A)** Diagrammatic representation of the experimental strategy. **(B--D)** Halo-tagged M~1~R was expressed transiently in sensory neurons and then treated with 100 nM MT7 or 1 μM PZ for 1 h. Cells were then lysed and Halo-M~1~R was pulled down using halo-linked resin. The halo tag was cleaved by TEV protease and the cleaved M~1~R associated multiprotein complex (MPC) was resolved in denaturing SDS-PAGE and immunoblotted using **(B)** anti-M~1~R, **(C)** anti-Gγ2/3/4/7, and **(D)** anti-Gα12/13 antibodies. **(E,F)** Scatter plot showing the relative amount of G proteins (Gα and Gγ, respectively) associated with M~1~R following drug treatment. The data represent mean ± SEM of three independent experiments. *p*-values (^∗∗∗∗^\<0.0001) were calculated by one-way ANOVA with Dunnett's *post hoc* multiple comparison test.](fnins-12-00402-g008){#F8}

![MT7 and pirenzepine elevated sequestration of trimeric G proteins in a protein complex associated with M~1~R in SH-SY5Y cells. **(A,B)** BN-PAGE analysis showing recruitment and sequestration of G proteins to M~1~R following MT7 treatment. GFP-M~1~R transfected cells were treated with 100 nM MT7 and incubated for 1 h. Cell lysates were then separated on 1D BN PAGE followed by 2D SDS-PAGE, **(A)** Control, **(B)** 100 nM MT7 treatment. Top panel: Coomassie stained gel piece showing 1D BN-PAGE separation of native page protein molecular weight marker. The red horizontal and vertical arrows indicate the direction of the 1D BN-PAGE and 2D SDS-PAGE, respectively. The blue rectangle shows PTMs of GFP-M~1~R associated with 1000 kDa and \>1200 kDa MPCs. The red circle indicates native form of the GFP-M~1~R associated with the MPCs. The red arrow connecting the red circles indicates shift of molecular weight in MPC due to recruitment of G proteins following drug treatment. The red rectangle in the bottom panel shows the co-migration of possible interacting G proteins with the MPCs.](fnins-12-00402-g009){#F9}

The 2D BN-PAGE/SDS-PAGE analysis revealed existence of 2 protein complexes at ∼900 and ∼1200 kDa equivalent molecular weights in Halo-M~1~R over-expressing SH-SY5Y cells (**Figures [9A,B](#F9){ref-type="fig"}**). Each complex was associated with a native ∼100 kDa Halo-tagged M~1~R protein and \>180 kDa fractions, the latter may be derived from different PTMs of the Halo-M~1~R. Treatment with 100 nM MT7 caused a major shift of the ∼900 kDa protein complex to the ∼1200 kDa protein complex within 1 h of treatment, suggestive of recruitment of putative interacting proteins (**Figure [9](#F9){ref-type="fig"}**, blue and red dotted areas). In contrast, untreated cells did not show any shift in the ∼900 kDa protein complex to the ∼1200 kDa protein complex indicating less or no recruitment of interacting proteins (**Figure [9A](#F9){ref-type="fig"}**). Further, when the same blots were immunoblotted with anti-Gα12/13 antibodies, the Gα12/13 proteins appeared as spots on a vertical line corresponding to the ∼1200 kDa protein complex in the drug treated cells which suggests possible co-migration and association with M~1~R (**Figures [9A,B](#F9){ref-type="fig"}**, bottom panel).

Discussion
==========

Our recent work has shown that sensory neurons derived from M~1~R null mice exhibit enhanced neurite outgrowth ([@B18]). We now demonstrate that over-expression of M~1~R inhibited neurite outgrowth, caused disruption of the tubulin cytoskeleton and blockade of mitochondrial trafficking in adult sensory neurons, all of which were rescued by exposure to selective or specific M~1~R antagonists. We then used overexpression of GFP-M~1~R to identify the molecular pathway components associated with specific M~1~R-mediated cellular phenotypes. Based on our data, we propose that ACh mediated signaling via M~1~R constrains neurite outgrowth via activation of Gα13 proteins, which in turn limits tubulin polymerization and mitochondrial trafficking within axons.

Overexpression of M~1~R in sensory neurons has biological consequences that likely arise from the presence of neuron-derived ACh in the culture environment. Cultured sensory neurons secrete endogenous ACh into the extracellular media to generate a local concentration in the range of approximately 16 μM ([@B18]). This far exceeds the ACh *K*~d~ of 25--35 nM measured in several regions of rat brain tissue ([@B43]) or the *K*~d~ of 0.2--0.4 nM measured using rat brain neurons ([@B63]; [@B3]). In the presence of abundant extracellular ACh, overexpressed. M~1~R will trigger activation of Gα13 proteins that leads to the dissociation of tubulin microtubules, as seen in **Figure [4](#F4){ref-type="fig"}**. The chemogenetically modified M~1~R-DREADD mutant significantly reduced M~1~R induced growth retardation (**Figure [2](#F2){ref-type="fig"}**). Thus, ACh-driven basal activity of M~1~R is responsible for neurite outgrowth suppression under conditions of M~1~R over-expression. In addition, we propose in normal un-transfected neurons that basal endogenous M~1~R signaling tonically suppresses neurite outgrowth by restricting mitochondrial (and potentially vesicular) transport, thereby explaining the ability of antimuscarinic drugs to prevent/reverse this constraint.

Knockdown of Gα13 in M~1~R-overexpressed neurons significantly reversed the M~1~R-induced growth inhibitory effect and protected from tubulin destabilization in growth cones (**Figure [7](#F7){ref-type="fig"}**). Gα13 is more abundant than Gα12 in sensory neurons and M~1~R was linked to activation of Gα12/13 type G proteins that leads to activation of small GTP binding protein Rho through mobilization of RhoGEF ([@B54]; [@B86]; [@B33]). Activation of Gα12/13 leads to stimulation of the Rho/Rho Kinase pathway via a subgroup of Rho guanine nucleotide exchange factors ([@B29]). Involvement of Rho and ROCK (Rho-associated coiled coil forming protein kinase) in agonist-induced neurite retraction and cell rounding has been reported in N1E-115 neuroblastoma cells ([@B38]). Dominant-negative p160-ROCK completely abolished this neurite retraction suggesting a clear link between RhoA-ROCK signaling and cytoskeleton disassembly ([@B38]). Activation of neuronal cannabinoid receptors linked to Gα12/13 proteins triggered rapid and reversible contraction of actinomyosin cytoskeleton through a Rho-GTPase and ROCK ([@B66]). Further, the CRISPR/Cas9 based knockout of Gα12/13 proteins in the HEK293 cell line augmented the abundance of polymerized tubulin (**Supplementary Figure [S1](#SM1){ref-type="supplementary-material"}**). HEK293 cells have been utilized as a model system for neuronal synapse formation ([@B12]) as they express neuronal proteins and have neuronal cell-lineage ([@B82]; [@B87]). Using a NanoBIT split luciferase based RhoA biosensor that detects Gq-induced RhoA activation showed that the RhoA signal is completely lost in the Gα12/13 KO cell (Mercier et al., manuscript in revision, personal communication).

Activated G proteins regulate tubulin polymerization ([@B77]) and tubulin binds directly to Gα or Gβγ subunits ([@B96]; [@B69]; [@B76]). Activated GTP bound Gα promotes microtubule instability by increasing the intrinsic hydrolysis of GTP-tubulin to the less polymer stable GDP-tubulin ([@B69], [@B68]). We have modelled this in **Figure [10](#F10){ref-type="fig"}**. Overexpression of Gα~q~ in a rat pituitary cell line showed a 50% decrease in the ratio of soluble to polymerized tubulin ([@B65]). There is considerable cell type and isoform specificity in Gα mediated tubulin cytoskeleton dynamics ([@B75]). We found that Gα12/13 and Gγ(2,3,4,7) were sequestered upon M~1~R antagonist binding (**Figures [8](#F8){ref-type="fig"}**, **[9](#F9){ref-type="fig"}**) and it is plausible that these factors also regulate tubulin polymerization in sensory neurons. In addition, some guanine nucleotide exchange factors (GEFs) for Rho GTPases, namely p115 RhoGEF ([@B45]), PDZ-RhoGEFs ([@B30]), and LARG ([@B88]) can act as direct couplers of Gα12/13 proteins to small GTPases such as RhoA, Rac1, and CDC42, all of which are known to influence microtubule dynamics ([@B34]). The Gα12/13-RhoGEF-RhoA pathway of GPCR has been implicated in many diseases ([@B86]). Interestingly, while Gα promotes tubulin disassembly by increasing the tubulin GTPase activity, Gβγ subunits preferentially associate with GDP-bound tubulin to promote polymerization and stability of the microtubule ([@B70]; [@B64]; [@B68]). Our data from non-crosslinked halo-pull down (**Figure [8](#F8){ref-type="fig"}**) and BN-PAGE analyses (**Figure [9](#F9){ref-type="fig"}**) show augmented association and occupancy of trimeric G-proteins (Gα12/13) to M~1~R during MT7 or PZ treatment, which indicates elevated sequestration of these proteins on M~1~R. We propose that muscarinic antagonist-induced sequestration of trimeric G-proteins restricts their dissociation from the overexpressed M~1~R associated protein complex and thereby limits their detrimental effect on tubulin polymerization (see **Figure [10](#F10){ref-type="fig"}**). Further, we posit that the same M~1~R suppression pathway is occurring in normal un-transfected neurons to limit cytoskeleton formation in axons and is counteracted by these drugs. However, this does not exclude the possibility that other pathways may be involved. For example, Ca^2+^ signaling/homeostasis are known to be responsible for the maintenance of cytoskeletal integrity ([@B92]). Cholinergic activation of M~1~R coupled with the Gq/11 protein generates cytosolic calcium transients via phospholipase-C signaling pathway ([@B49]). High Ca^2+^ may act to increase the intrinsic GTP hydrolysis of tubulin and directly destabilize growing microtubule ends without changing the effective concentration of tubulin ([@B62]). Therefore, it is possible that excessive cholinergic signaling may imbalance intracellular Ca^2+^ homeostasis and promotes tubulin destabilization. Antagonist mediated sequestration of G-proteins may limit this response and protect Ca^2+^ induced tubulin destabilization. However, further experimentation is required to prove this hypothesis. Insertion and site-directed mutagenesis based studies have revealed potential G-protein interaction sites in the i2 and i3 loops in mAChRs ([@B14]; [@B52]; [@B39]). Overexpression of mutated M~1~R for disruptive Gα13 binding and subsequent reversal of cholinergic tubulin destabilization effect would provide another means of testing. The exact binding site for Gα13 protein in M~1~R needs to be evaluated.

![Model explaining the effect of M~1~R overexpression and antagonism on tubulin associated cytoskeleton and mitochondrial trafficking. **(Left)** M~1~R overexpressing neurons have increased basal activity in response to secreted acetylcholine signaling through overexpressed receptor. This is turn causes recruitment of trimeric G proteins that destabilize tubulin polymers by increasing intrinsic GTPase activity of tubulin. The lack of tubulin cytoskeleton in M~1~R overexpressing neuron leads to decreased mitochondrial trafficking and stagnation of mitochondria in the neurites that impairs outgrowth. **(Right)** M~1~R overexpression in the presence of antagonists MT7 and pirenzepine (PZ) stabilizes tubulin polymerization. The antagonists bind to the M~1~R and may stabilize a specific structural ensemble, which in turn recruit trimeric G proteins. However, the antagonist mediated M~1~R structural ensemble may sequester the bound G proteins and makes them unavailable for exerting their effect on tubulin polymerization which in turn stabilizes microtubule cytoskeleton and promotes mitochondrial trafficking and neurite outgrowth.](fnins-12-00402-g010){#F10}

Overexpression of M~1~R restricted the number of active mitochondria in neurites, presumably through diminished trafficking as a direct consequence of overexpressed M~1~R-induced disruption of the cytoskeleton. The M~1~R antagonists, pirenzepine and MT7, were able to protect mitochondrial transport. Pirenzepine and MT7 also enhance mitochondrial oxygen consumption rate and respiratory complex activities through activation of the AMP-activated protein kinase (AMPK)/peroxisome proliferator-activated receptor γ coactivator-1α signaling axis ([@B18]). Mitochondrial function was also enhanced in sensory neuron cultures derived from M~1~R null mice. Thus, ACh signaling through M~1~R can negatively regulate mitochondrial phenotype at multiple levels in the neuron that include trafficking and positioning as well as fine regulation of activity of the respiratory complexes. Optimal regulation of mitochondrial function is critical in distal regions of sensory neurons which, in human peripheral nerve, can be up to a meter from the cell body ([@B81]). The architecture of sensory neurons poses an extreme cellular environment for mitochondrial distribution and a need to supply energy to the distal endings where energy demand is high ([@B11]; [@B22]). Any defect in mitochondrial function is likely to have a profound influence on the axon. Recent *in vivo* studies of mitochondrial transport along the saphenous nerve of adult mice revealed elevated anterograde transport of this organelle in axons undergoing high rates of depolarization and impulse conduction ([@B73]). Indeed, loss of function of mitochondrial proteins such as *bcl-w* or mitofusin-2 results in a length-dependent dying-back sensory neuropathy ([@B4]; [@B60]; [@B24]). Genetic ablation of mitochondrial transport also leads to axonal growth failure following axotomy in mice ([@B103]). In axons, approximately 30--40% of total mitochondria are constantly engaged in saltatory motion ([@B53]). It is plausible that the microtubule disruption induced by overexpression of M~1~R eliminated the basic framework for motor proteins to carry their mitochondrial cargo and potentially other vesicular cargos. As a result, the physical abundance of active mitochondria was diminished in the distal neuritis, which would be expected to deprive the neuronal growth cone of an essential supply of ATP, resulting in suppressed actin treadmilling and neurite outgrowth. This hypothesis, summarized in **Figure [10](#F10){ref-type="fig"}**, is further supported by reports that several microtubule-targeted chemotherapeutic agents, such as colchicine and vincristine, are known to induce a sensory neuropathy in which the distal aspect of the sensory axon gradually degenerates ([@B7]).

Our pre-clinical studies have demonstrated that selective and specific M~1~R antagonists promote neurite outgrowth in adult sensory neurons *in vitro* ([@B18]). MT7 and pirenzepine were also able to prevent or reverse the distal degenerative neuropathy characteristic of diabetes, chemotherapy-induced and HIV-induced peripheral neuropathy. In the present study, we have reinforced the finding that M~1~R antagonists are neuronal growth promoters using an unbiased automated high throughput neurite outgrowth measurement technique in a large cohort of sensory neurons. In addition, we have highlighted a molecular mechanism that indicates that treatment with these drugs stabilizes microtubules by sequestering Gα13 proteins and promotes microtubule-based axonal transport of mitochondria, which in turn augments neurite outgrowth. Peripheral neuropathy is a major cause of human morbidity with huge associated health care costs ([@B31]; [@B57]). One particularly encouraging implication of our identification of the endogenous M~1~R-mediated suppression of axonal outgrowth in sensory neurons is that antimuscarinic drugs that can prevent/reverse this process have already been widely used as approved drugs for other indications ([@B84]). Since small fiber axonal degeneration is an early feature of many peripheral neuropathies, the novel growth-regulating pathway we have identified could be mobilized to prevent or reverse distal neurodegeneration. Our studies support a previously unrecognized therapeutic potential for M~1~R antagonists in the treatment of peripheral neuropathies and unravels a novel pathway of cholinergic signaling mediated via control of microtubule dynamics through Gα13 signaling.
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Polymerized α-tubulin is augmented in Gα12/13 null HEK293 cells. **(A)** Immunoblots showing expression of Gα12, Gα13, and porin (VDAC1) in wild type and Gα12/13 null HEK293 cell. **(B)** Immunoblots showing the relative amount of polymerized tubulin in wild type and Gα12/13 null HEK293 cells. **(C)** In BN-PAGE based assay, polymerized tubulin was stabilized in microtubule stabilization buffer and resolved in native gradient gel. The polymerized tubulin microtubules are trapped in the native page at the top (∼1200 kDa) whereas the dimers and monomers migrated to lower molecular weight regions. The first dimension gel was denatured and the proteins were further separated in 2nd dimension SDS-PAGE and immunoblotted. The spots at ∼146 and ∼66 kDa represent α-tubulin dimer and monomers. The red dotted circle represents the polymerized tubulin. Green and blue arrows indicate direction of protein movement. **(D)** Scatter plot showing polymerized tubulin in wild type and Gα12/13 null HEK293 cell as revealed by polymerized tubulin and BN-Page based assays. In the BN-PAGE assay the polymerized tubulin was quantified based on the relative intensity of the monomeric tubulin. *N* = 3/4 independent experiments. Data represented as mean ± SEM, *p*-value by unpaired *t*-test. **(E)** Immunofluorescent images showing actin (phalloidin) and (α-tubulin) in HEK293 (Wild type: WT) and GNAS12/13 knockout (ΔGNAS12/13) cells. Scale bar: 20 μm.
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###### 

Actin and tubulin cytoskeleton in wild type and G12/13 KO cells. **(A,B)** Confocal immunofluorescent images showing F-actin (phalloidin stained, top panel, **A**) and tubulin (α-tubulin immunolabelled, bottom panel, **B**) cytoskeleton in GFP-M~1~R expressing wild type and G12/13 KO cells. Blue arrow indicates focal adhesions, yellow arrow indicates extended cytoplasmic processes enriched in tubulin. Scale bar: 20 μm.
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###### 

Effect of carbachol on tubulin cytoskeleton in M~1~R expressed wild type and G12/13 KO cells. Confocal immunofluorescence images showing the tubulin cytoskeleton. Yellow arrow indicates crest of the cell with dense packing of tubulin. White and blue arrows indicate elongated cytoplasmic processes enriched in tubulin. Blue arrow indicates localization of GFP-M~1~R in extended cytoplasmic processes. *Z* represents a particular optical slice in *Z*-stacked image series. Scale bar: 20 μm.
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